A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy
TROPHY-U-01 研究(队列 2)简明摘要:在无法接受顺铂类化疗的转移性尿路上皮癌患者中,免疫治疗后使用 sacituzumab govitecan 的疗效
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2548757
Grivas, Petros; Tagawa, Scott T; Jain, Rohit K; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P; Davis, Nancy; Sternberg, Cora N; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann